Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation

Amino Acids

Volumn 43, Issue 3, 2012, Pages 1243-1250

  Zhu, Jiuxin ^a   Xie, Rui ^a   Piao, Xianmei ^a   Hou, Yunlong ^a   Zhao, Chongbao ^a   Qiao, Guofen ^a   Yang, Baofeng ^a   Shi, Jialan ^a,b   Lu, Yanjie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Annexin V; Clot promoting activity; Endothelial cells; Homocysteine; Microparticles; Phosphatidylserine

Indexed keywords

HOMOCYSTEINE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROCOAGULANT; PROTEIN ANTIBODY; THROMBOPLASTIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CALCIFICATION; CELL ACTIVITY; CELL INTERACTION; CLOT PROMOTING ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; HUMAN; HUMAN CELL; LIPID TRANSPORT; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; BLOOD COAGULATION; CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; COAGULANTS; HOMOCYSTEINE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PHOSPHATIDYLSERINES; THROMBIN TIME;

EID: 84867062424     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1196-4     Document Type: Article

References (49)

1. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM, Willems GM (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267:17907-17912
2. Bach RR (2006) Tissue factor encryption. Arterioscler Thromb Vasc Biol 26:456-461
3. Brumatti G, Sheridan C, Martin SJ (2008) Expression and purification of recombinant annexin V for the detection of membrane alterations on apoptotic cells. Methods 44:235-240 (Pubitemid 351296441)
4. Butenas S, Orfeo T, Mann KG (2009) Tissue factor in coagulation: which+ where+ when+ Arterioscler Thromb Vasc Biol 29:1989-1996
5. Cai B, Shan L, Gong D, Pan Z, Ai J, Xu C, Lu Y, Yang B (2009) Homocysteine modulates sodium channel currents in human atrial myocytes. Toxicology 256:201-206
6. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS (2005) Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45:1467-1471 (Pubitemid 40615620)
7. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A (2009) Endothelial microparticles in diseases. Cell Tissue Res 335:143-151
8. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561 (Pubitemid 28225719)
9. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104:93-102 (Pubitemid 29534349)
10. Curro M, Condello S, Caccamo D, Ferlazzo N, Parisi G, Ientile R (2009) Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells. Amino Acids 36:725-730
11. Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR (2006) Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood 108:2237-2243 (Pubitemid 44497505)
12. den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM (2007) Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial. Blood 109:139-144 (Pubitemid 46053054)
13. Dong F, Zhang X, Li SY, Zhang Z, Ren Q, Culver B, Ren J (2005) Possible involvement of NADPH oxidase and JNK in homocysteine- induced oxidative stress and apoptosis in human umbilical vein endothelial cells. Cardiovasc Toxicol 5:9-20 (Pubitemid 40655439)
14. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 13:1327-1333 (Pubitemid 23271135)
15. Fu Y, Zhou J, Li H, Cao F, Su Y, Fan S, Li Y, Wang S, Li L, Gilbert GE, Shi J (2010) Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. Thromb Haemost 104:1235-1241
16. Hajjar KA (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873-2879 (Pubitemid 23182548)
17. Hajjar KA, Jacovina AT (1998) Modulation of annexin II by homocysteine: implications for atherothrombosis. J Investig Med 46:364-369 (Pubitemid 128455005)
18. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT (1998) Tissue plasminogen activator binding to the annexin II tail domain: direct modulation by homocysteine. J Biol Chem 273:9987-9993 (Pubitemid 28183100)
19. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407-413 (Pubitemid 29355767)
20. Hou J, Fu Y, Zhou J, Li W, Xie R, Cao F, Gilbert GE, Shi J (2011) Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets. Vox Sang 100:187-195
21. Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD, Hajjar KA (2009) Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 119:3384-3394
22. Jakubowski H (2011) Quality control in tRNA charging-editing of homocysteine. Acta Biochim Pol 58:149-163
23. Jakubowski H, Boers GH, Strauss KA (2008) Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J 22:4071-4076
24. Kerkeni M, Tnani M, Chuniaud L, Miled A, Maaroufi K, Trivin F (2006) Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone. Mol Cell Biochem 291:119-126 (Pubitemid 44725310)
25. Lambers JW, Cammenga M, König BW, Mertens K, Pannekoek H, van Mourik JA (1987) Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids. J Biol Chem 262:17492-17496 (Pubitemid 18032230)
26. Lee SJ, Kim KM, Namkoong S, Kim CK, Kang YC, Lee H, Ha KS, Han JA, Chung HT, Kwon YG, Kim YM (2005) Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 280:5781-5788 (Pubitemid 40280058)
27. Lentz SR, Sadler JE (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906-1914
28. Lentz SR, Sadler JE (1993) Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81:683-689 (Pubitemid 23040860)
29. McCully KS (2007) Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr 86:1563S-1568S (Pubitemid 350126271)
30. Mercié P, Garnier O, Lascoste L, Renard M, Closse C, Durrieu F, Marit G, Boisseau RM, Belloc F (2000) Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 5:403-411 (Pubitemid 32162622)
31. Nachman RL (1992) Review: Stratton lecture. Thrombosis and atherogenesis: molecular connections. Blood 79:1897-1906
32. Nishinaga M, Ozawa T, Shimada K (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 92:1381-1386 (Pubitemid 23273914)
33. Pera-Kajan J, Twardowski T, Jakubowski H (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids 32:561-572 (Pubitemid 46790938)
34. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157-171 (Pubitemid 46529055)
35. Reviakine II, Bergsma-Schutter W, Brisson A (1998) Growth of protein 2-D crystals on supported planar lipid bilayers imaged in situ by AFM. J Struct Biol 121:356-361
36. Rodgers GM, Conn MT (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75:895-901 (Pubitemid 20067188)
37. Rodgers GM, Kane WH (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909-1916 (Pubitemid 16062647)
38. Sauls DL, Warren M, Hoffman M (2011) Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin. Thromb Res 127:576-581
39. Shi J, Shi Y, Waehrens LN, Rasmussen JT, Heegaard CW, Gilbert GE (2006) Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A 69:1193-1201 (Pubitemid 46036176)
40. Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T, Ogihara T (2004) Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension 43:1208-1213 (Pubitemid 38696913)
41. Tait JF, Frankenberry DA, Shiang R, Murray JC, Adler DA, Disteche CM (1991) Chromosomal localization of the human gene for annexin V (placental anticoagulant protein I) to 4q26-q28. Cytogenet Cell Genet 57:187-192
42. Taube J, McWilliam N, Luddington R, Byrne CD, Baglin T (1999) Activated protein C resistance: effect of platelet activation, platelet-derived microparticles, and atherogenic lipoproteins. Blood 93:3792-3797 (Pubitemid 29249825)
43. Thambyrajah J, Townend JN (2000) Homocysteine and atherothrombosis- mechanisms for injury. Eur Heart J 21:967-974
44. Undas A, Brozek J, Jankowski M, Siudak Z, Szczeklik A, Jakubowski H (2006) Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 26:1397-1404 (Pubitemid 44305388)
45. Zhang G, Gurtu V, Kain SR, Yan G (1997) Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 23:525-531 (Pubitemid 27398205)
46. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, Kitajima S (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276:35867-35874
47. Zhou J, Liu S, Ma M, Hou J, Yu H, Lu C, Gilbert GE, Shi J (2009) Procoagulant activity and phosphatidylserine of amniotic fluid cells. Thromb Haemost 101:845-851
48. Zhou J, Shi J, Hou J, Cao F, Zhang Y, Rasmussen JT, Heegaard CW, Gilbert GE (2010) Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia. J Thromb Haemost 8:773-782
49. Zwaal RF, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121-1132 (Pubitemid 27079974)